Medtronic announced the launch of the Euphora semicompliant balloon dilatation catheter in CE mark-recognizing countries, introducing advanced deliverability and enhanced lesion access for complex coronary procedures.
June 5, 2015
Medtronic
Euphora Balloon Catheter
Medtronic officially launched the Euphora semicompliant balloon dilatation catheter in countries recognizing the CE (Conformité Européene) mark during February 2015.
The first successful patient procedure using the Euphora catheter was performed by Richard Edwards, M.D., consultant cardiologist at Freeman Hospital in Newcastle, United Kingdom.
“After performing the first patient case with Euphora, it is the most deliverable balloon catheter I have used. The exceptionally low crossing profile and pushability make it ideal for complex situations and workhorse lesions alike.”
Pre-dilatation using a semicompliant balloon helps physicians:
The delivery system incorporates PowerTrac technology designed to provide superior deliverability through tight and complex lesions compared with major competitors.
Features ultra-slim balloon material, tapered proprietary inner shaft design, and optimized mini-wrap technology to reduce balloon wall thickness and improve crossability.
Enhanced insertion and retraction force improve navigation during the Kissing Balloon Technique commonly used for bifurcated lesion treatment.
Reduced packaging size minimizes storage footprint in busy cath labs while improving product readability and workflow efficiency.
Improved crossability may reduce the need for multiple balloons during lesion preparation, potentially lowering procedural costs and improving cath lab efficiency.
With its low crossing profile, advanced deliverability, and procedural efficiency enhancements, the Euphora semicompliant balloon catheter represents Medtronic’s continued innovation in interventional cardiology solutions for complex coronary procedures.
